Annual Working Capital:
$458.04M-$73.23M(-13.78%)Summary
- As of today, AMRX annual working capital is $458.04 million, with the most recent change of -$73.23 million (-13.78%) on December 31, 2024.
- During the last 3 years, AMRX annual working capital has fallen by -$384.83 million (-45.66%).
- AMRX annual working capital is now -47.63% below its all-time high of $874.64 million, reached on December 31, 2020.
Performance
AMRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Working Capital:
$477.56M+$42.93M(+9.88%)Summary
- As of today, AMRX quarterly working capital is $477.56 million, with the most recent change of +$42.93 million (+9.88%) on June 30, 2025.
- Over the past year, AMRX quarterly working capital has increased by +$106.43 million (+28.68%).
- AMRX quarterly working capital is now -48.25% below its all-time high of $922.88 million, reached on March 31, 2021.
Performance
AMRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AMRX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -13.8% | +28.7% |
| 3Y3 Years | -45.7% | -14.8% |
| 5Y5 Years | -30.6% | -42.2% |
AMRX Working Capital Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -45.7% | at low | -31.3% | +28.7% |
| 5Y | 5-Year | -47.6% | at low | -48.3% | +28.7% |
| All-Time | All-Time | -47.6% | >+9999.0% | -48.3% | >+9999.0% |
AMRX Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $477.56M(+9.9%) |
| Mar 2025 | - | $434.63M(-5.1%) |
| Dec 2024 | $458.04M(-13.8%) | $458.04M(+9.6%) |
| Sep 2024 | - | $418.08M(+12.7%) |
| Jun 2024 | - | $371.13M(-32.0%) |
| Mar 2024 | - | $545.66M(+2.7%) |
| Dec 2023 | $531.27M(-19.4%) | $531.27M(-23.6%) |
| Sep 2023 | - | $695.47M(+7.9%) |
| Jun 2023 | - | $644.44M(+6.8%) |
| Mar 2023 | - | $603.62M(-8.4%) |
| Dec 2022 | $659.02M(-21.8%) | $659.02M(+9.5%) |
| Sep 2022 | - | $601.84M(+7.4%) |
| Jun 2022 | - | $560.54M(-28.8%) |
| Mar 2022 | - | $787.63M(-6.6%) |
| Dec 2021 | $842.87M(-3.6%) | $842.87M(-6.7%) |
| Sep 2021 | - | $903.00M(+1.4%) |
| Jun 2021 | - | $890.61M(-3.5%) |
| Mar 2021 | - | $922.88M(+5.5%) |
| Dec 2020 | $874.64M(+32.6%) | $874.64M(-0.1%) |
| Sep 2020 | - | $875.83M(+6.1%) |
| Jun 2020 | - | $825.86M(+2.1%) |
| Mar 2020 | - | $808.63M(+22.6%) |
| Dec 2019 | $659.80M(-10.0%) | $659.80M(-1.7%) |
| Sep 2019 | - | $670.92M(+4.9%) |
| Jun 2019 | - | $639.69M(-4.3%) |
| Mar 2019 | - | $668.44M(-8.8%) |
| Dec 2018 | $732.79M(+54.3%) | $732.79M(+7.4%) |
| Sep 2018 | - | $682.03M(+0.6%) |
| Jun 2018 | - | $678.16M(>+9900.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $475.05M(+53.3%) | $475.05M(+53.3%) |
| Dec 2016 | $309.82M(-37.5%) | - |
| Dec 2016 | - | $309.82M(-15.4%) |
| Sep 2016 | - | $366.05M(-28.3%) |
| Jun 2016 | - | $510.77M(+6.4%) |
| Mar 2016 | - | $479.83M(-3.1%) |
| Dec 2015 | $495.31M(-13.4%) | $495.31M(-11.9%) |
| Sep 2015 | - | $562.31M(+18.0%) |
| Jun 2015 | - | $476.44M(+34.8%) |
| Mar 2015 | - | $353.48M(-38.2%) |
| Dec 2014 | $571.75M(+13.0%) | $571.75M(-1.6%) |
| Sep 2014 | - | $580.86M(+3.1%) |
| Jun 2014 | - | $563.20M(+7.0%) |
| Mar 2014 | - | $526.23M(+4.0%) |
| Dec 2013 | $505.85M(+26.4%) | $505.85M(-6.7%) |
| Sep 2013 | - | $542.19M(+2.6%) |
| Jun 2013 | - | $528.35M(+1.5%) |
| Mar 2013 | - | $520.72M(+30.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $400.25M(-9.7%) | $400.25M(+3.9%) |
| Sep 2012 | - | $385.27M(+13.4%) |
| Jun 2012 | - | $339.60M(-7.6%) |
| Mar 2012 | - | $367.42M(-17.1%) |
| Dec 2011 | $443.07M(+12.4%) | $443.07M(+4.7%) |
| Sep 2011 | - | $423.01M(+2.7%) |
| Jun 2011 | - | $411.76M(+2.4%) |
| Mar 2011 | - | $402.15M(+2.0%) |
| Dec 2010 | $394.28M(+131.7%) | $394.28M(+6.5%) |
| Sep 2010 | - | $370.18M(+80.9%) |
| Jun 2010 | - | $204.64M(-33.2%) |
| Mar 2010 | - | $306.25M(+80.0%) |
| Dec 2009 | $170.14M(+34.4%) | $170.14M(+32.9%) |
| Sep 2009 | - | $128.03M(-5.0%) |
| Jun 2009 | - | $134.75M(+4.7%) |
| Mar 2009 | - | $128.73M(+1.6%) |
| Dec 2008 | $126.64M(+15.0%) | $126.64M(+29.3%) |
| Sep 2008 | - | $97.91M(-15.0%) |
| Jun 2008 | - | $115.14M(+4.6%) |
| Dec 2007 | $110.11M(+34.4%) | $110.11M(+34.4%) |
| Dec 2006 | $81.92M(+46.8%) | $81.92M(-30.7%) |
| Dec 2005 | $55.80M(+331.5%) | - |
| Sep 2004 | - | $118.18M(-0.3%) |
| Jun 2004 | - | $118.57M(+630.4%) |
| Mar 2004 | - | $16.23M(+25.5%) |
| Dec 2003 | $12.93M(+161.4%) | $12.93M(-36.0%) |
| Sep 2003 | - | $20.21M(-20.3%) |
| Jun 2003 | - | $25.35M(+653.4%) |
| Mar 2003 | - | $3.37M(-32.0%) |
| Dec 2002 | $4.95M(-86.3%) | $4.95M(-79.0%) |
| Sep 2002 | - | $23.56M(-20.2%) |
| Jun 2002 | - | $29.52M(-2.1%) |
| Mar 2002 | - | $30.14M(-16.7%) |
| Dec 2001 | $36.18M(+103.2%) | $36.18M(-16.3%) |
| Sep 2001 | - | $43.24M(-8.7%) |
| Jun 2001 | - | $47.39M(+240.1%) |
| Mar 2001 | - | $13.93M(-21.7%) |
| Dec 2000 | $17.80M(+185.0%) | $17.80M(+153.2%) |
| Sep 2000 | - | $7.03M(-45.6%) |
| Jun 2000 | - | $12.93M(-30.0%) |
| Mar 2000 | - | $18.46M(+195.6%) |
| Dec 1999 | $6.25M(+2017.6%) | $6.25M(+94.3%) |
| Sep 1999 | - | $3.21M(-6.9%) |
| Jun 1999 | - | $3.46M(+47.4%) |
| Mar 1999 | - | $2.34M(+694.6%) |
| Dec 1998 | $295.00K | $295.00K(-54.3%) |
| Sep 1998 | - | $646.00K(-54.2%) |
| Jun 1998 | - | $1.41M(-47.4%) |
| Mar 1998 | - | $2.68M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual working capital?
- What is the all-time high annual working capital for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual working capital year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly working capital?
- What is the all-time high quarterly working capital for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly working capital year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual working capital?
The current annual working capital of AMRX is $458.04M
What is the all-time high annual working capital for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual working capital is $874.64M
What is Amneal Pharmaceuticals, Inc. annual working capital year-on-year change?
Over the past year, AMRX annual working capital has changed by -$73.23M (-13.78%)
What is Amneal Pharmaceuticals, Inc. quarterly working capital?
The current quarterly working capital of AMRX is $477.56M
What is the all-time high quarterly working capital for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly working capital is $922.88M
What is Amneal Pharmaceuticals, Inc. quarterly working capital year-on-year change?
Over the past year, AMRX quarterly working capital has changed by +$106.43M (+28.68%)